Progress Toward Regional Measles Elimination — Worldwide, 2000–2020

In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030) uses measles incidence as an indicator of the strength of immuniza...

Full description

Saved in:

Bibliographic Details
Published in:	MMWR. Morbidity and mortality weekly report Vol. 70; no. 45; pp. 1563 - 1569
Main Authors:	Dixon, Meredith G., Ferrari, Matt, Antoni, Sebastien, Li, Xi, Portnoy, Allison, Lambert, Brian, Hauryski, Sarah, Hatcher, Cynthia, Nedelec, Yoann, Patel, Minal, Alexander, James P., Steulet, Claudia, Gacic-Dobo, Marta, Rota, Paul A., Mulders, Mick N., Bose, Anindya S., Rosewell, Alexander, Kretsinger, Katrina, Crowcroft, Natasha S.
Format:	Journal Article Newsletter
Language:	English
Published:	United States Centers for Disease Control & Prevention (CDC) 12.11.2021 U.S. Government Printing Office U.S. Center for Disease Control Centers for Disease Control and Prevention
Subjects:	Child Coronaviruses COVID-19 vaccines Deaths Disease Eradication Disease transmission Dosage Elimination Epidemics Estimates Fatalities Full Report Global Health - statistics & numerical data Humans Immunity Immunization Immunization Programs Incidence Infant Measles Measles - epidemiology Measles - prevention & control Measles Vaccine - administration & dosage Medical laboratories Mortality Pandemics Public health Regions Rubella Surveillance Vaccination Vaccines World Health Organization Brazil Nigeria
ISSN:	0149-2195, 1545-861X, 1545-861X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030) uses measles incidence as an indicator of the strength of immunization systems. The Measles-Rubella Strategic Framework 2021-2030 and the Measles Outbreaks Strategic Response Plan 2021-2023** are aligned with the IA2030 and highlight robust measles surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children. This report describes progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and updates a previous report (2). During 2000-2010, estimated MCV first dose (MCV1) coverage increased globally from 72% to 84%, peaked at 86% in 2019, but declined to 84% in 2020 during the COVID-19 pandemic. All countries conducted measles surveillance, although fewer than one third achieved the sensitivity indicator target of ≥2 discarded cases per 100,000 population in 2020. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, rebounded to 120 in 2019, before falling to 22 in 2020. During 2000-2020, the annual number of estimated measles deaths decreased 94%, from 1,072,800 to 60,700, averting an estimated 31.7 million measles deaths. To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 MCV doses, implement robust surveillance, and identify and close immunity gaps.
AbstractList	In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles† in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030)§ uses measles incidence as an indicator of the strength of immunization systems. The Measles-Rubella Strategic Framework 2021-2030¶ and the Measles Outbreaks Strategic Response Plan 2021-2023** are aligned with the IA2030 and highlight robust measles surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children. This report describes progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and updates a previous report (2). During 2000-2010, estimated MCV first dose (MCV1) coverage increased globally from 72% to 84%, peaked at 86% in 2019, but declined to 84% in 2020 during the COVID-19 pandemic. All countries conducted measles surveillance, although fewer than one third achieved the sensitivity indicator target of ≥2 discarded†† cases per 100,000 population in 2020. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, rebounded to 120 in 2019, before falling to 22 in 2020. During 2000-2020, the annual number of estimated measles deaths decreased 94%, from 1,072,800 to 60,700, averting an estimated 31.7 million measles deaths. To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 MCV doses, implement robust surveillance, and identify and close immunity gaps.In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles† in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030)§ uses measles incidence as an indicator of the strength of immunization systems. The Measles-Rubella Strategic Framework 2021-2030¶ and the Measles Outbreaks Strategic Response Plan 2021-2023** are aligned with the IA2030 and highlight robust measles surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children. This report describes progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and updates a previous report (2). During 2000-2010, estimated MCV first dose (MCV1) coverage increased globally from 72% to 84%, peaked at 86% in 2019, but declined to 84% in 2020 during the COVID-19 pandemic. All countries conducted measles surveillance, although fewer than one third achieved the sensitivity indicator target of ≥2 discarded†† cases per 100,000 population in 2020. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, rebounded to 120 in 2019, before falling to 22 in 2020. During 2000-2020, the annual number of estimated measles deaths decreased 94%, from 1,072,800 to 60,700, averting an estimated 31.7 million measles deaths. To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 MCV doses, implement robust surveillance, and identify and close immunity gaps. In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030) uses measles incidence as an indicator of the strength of immunization systems. The Measles-Rubella Strategic Framework 2021-2030 and the Measles Outbreaks Strategic Response Plan 2021-2023** are aligned with the IA2030 and highlight robust measles surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children. This report describes progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and updates a previous report (2). During 2000-2010, estimated MCV first dose (MCV1) coverage increased globally from 72% to 84%, peaked at 86% in 2019, but declined to 84% in 2020 during the COVID-19 pandemic. All countries conducted measles surveillance, although fewer than one third achieved the sensitivity indicator target of ≥2 discarded cases per 100,000 population in 2020. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, rebounded to 120 in 2019, before falling to 22 in 2020. During 2000-2020, the annual number of estimated measles deaths decreased 94%, from 1,072,800 to 60,700, averting an estimated 31.7 million measles deaths. To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 MCV doses, implement robust surveillance, and identify and close immunity gaps. What is already known about this topic? All six World Health Organization (WHO) regions remain committed to measles elimination. What is added by this report? Annual reported measles incidence decreased globally during 2000–2016, increased in all regions during 2017–2019, then decreased in 2020. Measles surveillance, already suboptimal, worsened in 2020. Since 2000, estimated measles deaths decreased 94%. Measles vaccination has prevented an estimated 31.7 million deaths worldwide. No WHO region has achieved and maintained measles elimination. What are the implications for public health practice? To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 doses of measles-containing vaccine, implement robust surveillance, and identify and close immunity gaps.
Audience	Professional
Author	Portnoy, Allison Gacic-Dobo, Marta Dixon, Meredith G. Li, Xi Mulders, Mick N. Antoni, Sebastien Alexander, James P. Rota, Paul A. Steulet, Claudia Patel, Minal Hatcher, Cynthia Bose, Anindya S. Kretsinger, Katrina Ferrari, Matt Lambert, Brian Hauryski, Sarah Rosewell, Alexander Nedelec, Yoann Crowcroft, Natasha S.
Author_xml	– sequence: 1 givenname: Meredith G. surname: Dixon fullname: Dixon, Meredith G. – sequence: 2 givenname: Matt surname: Ferrari fullname: Ferrari, Matt – sequence: 3 givenname: Sebastien surname: Antoni fullname: Antoni, Sebastien – sequence: 4 givenname: Xi surname: Li fullname: Li, Xi – sequence: 5 givenname: Allison surname: Portnoy fullname: Portnoy, Allison – sequence: 6 givenname: Brian surname: Lambert fullname: Lambert, Brian – sequence: 7 givenname: Sarah surname: Hauryski fullname: Hauryski, Sarah – sequence: 8 givenname: Cynthia surname: Hatcher fullname: Hatcher, Cynthia – sequence: 9 givenname: Yoann surname: Nedelec fullname: Nedelec, Yoann – sequence: 10 givenname: Minal surname: Patel fullname: Patel, Minal – sequence: 11 givenname: James P. surname: Alexander fullname: Alexander, James P. – sequence: 12 givenname: Claudia surname: Steulet fullname: Steulet, Claudia – sequence: 13 givenname: Marta surname: Gacic-Dobo fullname: Gacic-Dobo, Marta – sequence: 14 givenname: Paul A. surname: Rota fullname: Rota, Paul A. – sequence: 15 givenname: Mick N. surname: Mulders fullname: Mulders, Mick N. – sequence: 16 givenname: Anindya S. surname: Bose fullname: Bose, Anindya S. – sequence: 17 givenname: Alexander surname: Rosewell fullname: Rosewell, Alexander – sequence: 18 givenname: Katrina surname: Kretsinger fullname: Kretsinger, Katrina – sequence: 19 givenname: Natasha S. surname: Crowcroft fullname: Crowcroft, Natasha S.
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/34758014$$D View this record in MEDLINE/PubMed
BookMark	eNp1ktFqFDEUhoNU7LZ6650yKBQvnDXJJJnJjVBKrUJFkYrehWzmzGxKZrJNZl1613fQJ-yTmO22a7esCSSQfP85OSf_HtrpfQ8IPSd4TDiv-LuuW4Rx15WYcU0eoRHhjOeVID930AgTJnNKJN9FezGe4-Uo8BO0W7CSV-l2hE6-Bt8GiDE78wsd6uwbtNb32mWfQUcHMTt2trO9HtJpdn31J_vhg6sXtoa3GU3xrq9-U0zxU_S40S7Cs9t9H33_cHx29DE__XLy6ejwNDeCkSGvQBsjai0pJ4JOOCFYEg6NBCOqijdSk7SKVFgtJlIWwJipS6lLzHGJZVPso_eruLP5pIPaQD8E7dQs2E6HS-W1VZs3vZ2q1v9SVSqY4iIFeHUbIPiLOcRBBZj5MERFS84lrgrKEvTmAdTZaMA53YOfJ5RLwQSWXCT09QpttQNl-8antGaJq0NRUcYJFlWi8i1UCz2kN6YfbWw63uDHW_g0a-is2So4uCeYgnbDNHo3X35b3ARf3m_gunN3lviX2gQfY4BmjRCsbjynlp5Td55LAvZAYOxw45f0Zuv-L3uxkp3HwYd1EloSXBJCir_58OMh
CitedBy_id	crossref_primary_10_1016_j_vaccine_2022_05_009 crossref_primary_10_1038_s41467_024_53415_x crossref_primary_10_3389_fpubh_2024_1359572 crossref_primary_10_29254_2077_4214_2024_1_172_189_194 crossref_primary_10_1016_j_jinf_2023_01_009 crossref_primary_10_1016_j_isci_2023_107721 crossref_primary_10_3390_ijerph191711044 crossref_primary_10_1007_s13346_022_01130_9 crossref_primary_10_1016_j_ijregi_2023_04_004 crossref_primary_10_1017_S0950268824000426 crossref_primary_10_1007_s15010_024_02186_0 crossref_primary_10_1016_j_imu_2024_101548 crossref_primary_10_1016_j_vaccine_2023_03_043 crossref_primary_10_1097_QAD_0000000000003634 crossref_primary_10_1080_10255842_2025_2485374 crossref_primary_10_3390_vaccines11081389 crossref_primary_10_1016_j_jinf_2023_04_017 crossref_primary_10_11648_j_wjph_20251003_31 crossref_primary_10_1111_ped_15430 crossref_primary_10_3389_fpubh_2022_1037157 crossref_primary_10_1016_j_ijregi_2023_05_003 crossref_primary_10_1016_j_vaccine_2023_12_047 crossref_primary_10_1186_s12879_024_09816_w crossref_primary_10_3390_jcm11041145 crossref_primary_10_1093_jpids_piac011 crossref_primary_10_1186_s12879_022_07703_w crossref_primary_10_3390_vaccines10111859 crossref_primary_10_1016_j_vaccine_2024_02_005 crossref_primary_10_3389_fped_2022_979769 crossref_primary_10_1140_epjp_s13360_024_05368_9 crossref_primary_10_1590_1413_81232023282_19172022en crossref_primary_10_1099_jmm_0_001855 crossref_primary_10_3389_fpubh_2022_1000906 crossref_primary_10_3389_ijph_2024_1606997 crossref_primary_10_1128_jvi_01874_23 crossref_primary_10_1080_23744235_2024_2339870 crossref_primary_10_1177_00333549241249672 crossref_primary_10_1186_s13063_022_06493_5 crossref_primary_10_15585_mmwr_mm7147a1 crossref_primary_10_1093_ofid_ofad700 crossref_primary_10_1186_s12889_025_22750_z crossref_primary_10_1002_sim_9951 crossref_primary_10_1016_S2468_2667_23_00130_5 crossref_primary_10_3389_fmicb_2024_1475144 crossref_primary_10_1002_jmv_29003 crossref_primary_10_1016_j_jvacx_2025_100714 crossref_primary_10_1016_j_vaccine_2024_01_048 crossref_primary_10_3390_v14061186 crossref_primary_10_1186_s12889_023_17082_9 crossref_primary_10_1016_j_pulmoe_2023_07_002 crossref_primary_10_3390_vaccines12070810 crossref_primary_10_1016_j_omtm_2024_101398 crossref_primary_10_1093_jtm_taab182 crossref_primary_10_1038_s41598_024_60120_8 crossref_primary_10_1093_cid_ciac674 crossref_primary_10_1590_1413_81232023282_19172022 crossref_primary_10_3389_fpubh_2024_1395802 crossref_primary_10_1016_j_lanwpc_2022_100495 crossref_primary_10_1002_jmv_27827 crossref_primary_10_54393_pbmj_v8i8_1238 crossref_primary_10_1016_j_ijid_2023_12_007 crossref_primary_10_1016_j_vaccine_2024_05_060 crossref_primary_10_1186_s12879_023_08199_8 crossref_primary_10_1016_j_vaccine_2023_01_015 crossref_primary_10_1093_cid_ciab979 crossref_primary_10_1016_S2468_2667_24_00181_6 crossref_primary_10_47183_mes_2024_26_3_40_50 crossref_primary_10_1016_j_vacune_2024_10_002 crossref_primary_10_1136_bmj_n2755 crossref_primary_10_3389_fped_2023_1212658 crossref_primary_10_1016_j_vaccine_2022_10_040 crossref_primary_10_15585_mmwr_mm7106a2 crossref_primary_10_1007_s12519_024_00859_2 crossref_primary_10_1016_j_jinf_2025_106531 crossref_primary_10_2147_RMHP_S406933 crossref_primary_10_1111_1348_0421_13030 crossref_primary_10_1136_bmjgh_2023_011861 crossref_primary_10_15789_2220_7619_TSO_17893 crossref_primary_10_1080_14760584_2024_2367451 crossref_primary_10_7759_cureus_81292 crossref_primary_10_1016_j_jmii_2023_01_012 crossref_primary_10_1080_21645515_2024_2375081 crossref_primary_10_1136_bmjopen_2023_072990 crossref_primary_10_1038_s41467_022_33832_6 crossref_primary_10_2196_77195
Cites_doi	10.1002/sim.8290 10.1093/infdis/jir100 10.1016/S2214-109X(18)30537-0 10.15585/mmwr.mm6945a6
ContentType	Journal Article Newsletter
Copyright	COPYRIGHT 2021 U.S. Government Printing Office Published 2021. This article is a U.S. Government work and is in the public domain in the USA.
Copyright_xml	– notice: COPYRIGHT 2021 U.S. Government Printing Office – notice: Published 2021. This article is a U.S. Government work and is in the public domain in the USA.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 0-V 3V. 4T- 7RV 7X7 7XB 88C 88E 88F 88J 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA ALSLI AN0 ATCPS AZQEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 M0R M0S M0T M1P M1Q M2O M2R MBDVC NAPCQ PATMY PHGZM PHGZT PJZUB PKEHL POGQB PPXIY PQEST PQQKQ PQUKI PRINS PRQQA PYCSY Q9U S0X 5PM
DOI	10.15585/mmwr.mm7045a1
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic ProQuest Social Sciences Premium Collection【Remote access available】 ProQuest Central (Corporate) Docstoc Nursing & allied health premium. Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Military Database (Alumni Edition) Social Science Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Social Science Premium Collection British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central - New (Subscription) Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Military Database Research Library (subscription) Social Science Database Research Library (Corporate) Nursing & Allied Health Premium Environmental Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest Sociology & Social Sciences Collection ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Social Sciences Environmental Science Collection ProQuest Central Basic SIRS Editorial PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Military Collection Sociology & Social Sciences Collection ProQuest Central China ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Social Science Premium Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Environmental Science Collection Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Social Science Journals ProQuest Social Sciences Premium Collection ProQuest One Academic UKI Edition Docstoc ProQuest Health Management (Alumni Edition) Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Sociology & Social Sciences Collection ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Social Science Journals (Alumni Edition) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Agricultural & Environmental Science Collection ProQuest Research Library ProQuest Public Health ProQuest One Social Sciences ProQuest Central Basic British Nursing Index with Full Text ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Military Collection (Alumni Edition) ProQuest Medical Library ProQuest Central (Alumni)
DatabaseTitleList	MEDLINE - Academic MEDLINE Research Library Prep
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Economics Public Health
EISSN	1545-861X
EndPage	1569
ExternalDocumentID	PMC8580203 A682451068 34758014 10_15585_mmwr_mm7045a1 27107111
Genre	Journal Article
GeographicLocations	Brazil Nigeria
GeographicLocations_xml	– name: Nigeria – name: Brazil
GroupedDBID	--- -DZ -~X 0-V 04C 123 29M 2WC 36B 44B 5Q2 6PF 7RV 7X7 7XC 85S 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 96U 9K5 A8Z AAWTL ABDBF ABPPZ ABUWG ACUHS ADAAO ADOJX AEUYN AFAZI AFKRA AFRAH AHIZY AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI AN0 AQUVI ARALO ATCPS AXR AZQEC B0M BAAKF BENPR BHPHI BKEYQ BKNYI BNQBC BPHCQ BVXVI CCPQU DIK DWQXO E3Z EAD EAP EAS EBB EBC EBD EBS EBX ECF ECGQY ECI ECP ECT EHB EHE EHN EIHBH EJD EMB EMK EMOBN ENC ENX EPL EPT ESX EV9 EX3 F5P F8P FAC FAL FJD FJW FRP FYUFA GNUQQ GUQSH GX1 HCIFZ HMCUK HYE IAO IBB IEA IHR IHW INH IOF IPO ITC JENOY JST K9- KQ8 M0R M0T M1P M1Q M2O M2R NAPCQ NB9 NEJ OK1 OVT PATMY PCD PGMZT PHGZM PHGZT PQQKQ PROAC PSQYO PV9 PYCSY Q2X QWV Q~Q RGD RGQ RNS RPM RWL RXW RZL S0X SJN SV3 TAE TAF TN5 TR2 TUS U5U UKHRP UNMZH W2D WH7 WOW WQ9 XSB XZL YQT YRT ZAC ~8M AAYXX ABBHK AEOZU AEUPB AFFHD BIPZW CITATION IPSME JAAYA JBMMH JHFFW JKQEH JLEZI JLXEF JPL PJZUB PPXIY PRQQA SA0 CGR CUY CVF ECM EIF NPM 7X8 ESTFP 3V. 4T- 7XB 8FK K9. MBDVC PKEHL POGQB PQEST PQUKI PRINS Q9U 5PM
ID	FETCH-LOGICAL-c641t-8eacc6da925162b5110915ef9ec6885f9a185f6585d6b993e44cd79a7050709f3
IEDL.DBID	BENPR
ISICitedReferencesCount	86
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000718550800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0149-2195 1545-861X
IngestDate	Tue Nov 04 01:58:04 EST 2025 Fri Nov 14 18:47:03 EST 2025 Sun Nov 09 11:27:58 EST 2025 Sat Nov 29 13:17:55 EST 2025 Sat Nov 29 11:44:04 EST 2025 Sat Nov 29 10:20:32 EST 2025 Thu May 22 21:21:55 EDT 2025 Mon Jul 21 05:50:00 EDT 2025 Tue Nov 18 22:19:06 EST 2025 Sat Nov 29 03:50:04 EST 2025 Thu Jul 03 21:31:12 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	false
IsScholarly	false
Issue	45
Language	English
License	All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c641t-8eacc6da925162b5110915ef9ec6885f9a185f6585d6b993e44cd79a7050709f3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://pubmed.ncbi.nlm.nih.gov/PMC8580203
PMID	34758014
PQID	2755908324
PQPubID	23479
PageCount	7
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_8580203 proquest_reports_2755908324 proquest_miscellaneous_2596460956 gale_infotracmisc_A682451068 gale_infotracgeneralonefile_A682451068 gale_infotracacademiconefile_A682451068 gale_healthsolutions_A682451068 pubmed_primary_34758014 crossref_primary_10_15585_mmwr_mm7045a1 crossref_citationtrail_10_15585_mmwr_mm7045a1 jstor_primary_27107111
PublicationCentury	2000
PublicationDate	2021-11-12
PublicationDateYYYYMMDD	2021-11-12
PublicationDate_xml	– month: 11 year: 2021 text: 2021-11-12 day: 12
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: Atlanta
PublicationTitle	MMWR. Morbidity and mortality weekly report
PublicationTitleAlternate	MMWR Morb Mortal Wkly Rep
PublicationYear	2021
Publisher	Centers for Disease Control & Prevention (CDC) U.S. Government Printing Office U.S. Center for Disease Control Centers for Disease Control and Prevention
Publisher_xml	– name: Centers for Disease Control & Prevention (CDC) – name: U.S. Government Printing Office – name: U.S. Center for Disease Control – name: Centers for Disease Control and Prevention
References	Patel (key-10.15585/mmwr.mm7045a1-202111100620-R2) 2020; 69 key-10.15585/mmwr.mm7045a1-202111100620-R4 Eilertson (key-10.15585/mmwr.mm7045a1-202111100620-R3) 2019; 38 World Health Organization (key-10.15585/mmwr.mm7045a1-202111100620-R6) 2011; 204 World Health Organization (key-10.15585/mmwr.mm7045a1-202111100620-R7) 2017; 92 key-10.15585/mmwr.mm7045a1-202111100620-R1 Portnoy (key-10.15585/mmwr.mm7045a1-202111100620-R5) 2019; 7
References_xml	– volume: 38 start-page: 4146 year: 2019 ident: key-10.15585/mmwr.mm7045a1-202111100620-R3 article-title: Estimation and prediction for a mechanistic model of measles transmission using particle filtering and maximum likelihood estimation. publication-title: Stat Med doi: 10.1002/sim.8290 – volume: 204 start-page: S4 year: 2011 ident: key-10.15585/mmwr.mm7045a1-202111100620-R6 article-title: Proceedings of the Global Technical Consultation to assess the feasibility of measles eradication, 28-30 July 2010. publication-title: J Infect Dis doi: 10.1093/infdis/jir100 – volume: 7 start-page: e472 year: 2019 ident: key-10.15585/mmwr.mm7045a1-202111100620-R5 article-title: Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis. publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(18)30537-0 – ident: key-10.15585/mmwr.mm7045a1-202111100620-R4 – ident: key-10.15585/mmwr.mm7045a1-202111100620-R1 – volume: 69 start-page: 1700 year: 2020 ident: key-10.15585/mmwr.mm7045a1-202111100620-R2 article-title: Progress toward regional measles elimination—worldwide, 2000–2019. publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6945a6 – volume: 92 start-page: 205 year: 2017 ident: key-10.15585/mmwr.mm7045a1-202111100620-R7 article-title: Measles vaccines: WHO position paper—April 2017. publication-title: Wkly Epidemiol Rec
SSID	ssj0000030
Score	2.38618
Snippet	In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles in five of the six World Health... In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles† in five of the six World Health... What is already known about this topic? All six World Health Organization (WHO) regions remain committed to measles elimination. What is added by this report?...
SourceID	pubmedcentral proquest gale pubmed crossref jstor
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1563
SubjectTerms	Child Coronaviruses COVID-19 vaccines Deaths Disease Eradication Disease transmission Dosage Elimination Epidemics Estimates Fatalities Full Report Global Health - statistics & numerical data Humans Immunity Immunization Immunization Programs Incidence Infant Measles Measles - epidemiology Measles - prevention & control Measles Vaccine - administration & dosage Medical laboratories Mortality Pandemics Public health Regions Rubella Surveillance Vaccination Vaccines World Health Organization
Title	Progress Toward Regional Measles Elimination — Worldwide, 2000–2020
URI	https://www.jstor.org/stable/27107111 https://www.ncbi.nlm.nih.gov/pubmed/34758014 https://www.proquest.com/docview/2596460956 https://www.proquest.com/docview/2755908324 https://pubmed.ncbi.nlm.nih.gov/PMC8580203
Volume	70
WOSCitedRecordID	wos000718550800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Environmental Science Database customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: PATMY dateStart: 20141129 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: M0T dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Military Database customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: M1Q dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/military providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: BENPR dateStart: 20141129 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central Consumer Health Database (via ProQuest) customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: M0R dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: 7X7 dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Nursing & Allied Health Database customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: 7RV dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Research library customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: M2O dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: 8C1 dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Social Science Database customDbUrl: eissn: 1545-861X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000030 issn: 0149-2195 databaseCode: M2R dateStart: 20141129 isFulltext: true titleUrlDefault: https://search.proquest.com/socscijournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoiwQS4lEohJYSJASXhsZOYjsnVKotXLosqwXtLfI6TllpN1s2W3rtf4Bf2F_CjOOEBhUuXEaKMnlpXt844xlCXmoIAbGRUaCSiQhiqWgw0WCPQmgtFai1znM7bEL0-3I8Tgduwa1yZZWNT7SOOl9oXCPfZyLB8dwQ_9-efgtwahT-XXUjNNbIBqMRBT3feNfrD4ZXALCdNoJ5QAC2mbi2jQmA5P35_Hz5Zj4XAGoU7YQl55zrAsXroOefFZRXQtLRvf_9mPvkrgOj_kGtPQ_IDVNuklvNXuVqk9ypV_X8erPSQ_J-gOVc4Bz9kS239YfmxK4l-sdGVTNT-b2ZHROG4vYvL376tljnfJqbPR-361xe_GAAHR-Rz0e90eGHwI1iCDSP6SqQ4J81z1UKcIizSYJ9SmliitRoLmVSpArifgFoJsn5BCCPiWOdi1SJEPBmmBbRFlkvF6V5QnwqC06L0MjEsJizUIFL4IIrHVIFmTr1SNBIItOuTzmOy5hlmK-g5DKUXNZIziOvW_7TukPHXzmfo2Czeodpa9rZAZcsBt_EJdzLcqBxwzO1cnsU4M2xTVaH81WH86RuEn4d406HEaxXd05vWS1rX50B5BMQgDzyolGdDK_BWrjSLM6qDBJWHmOfQO6R7ZbH_WLKfquWRx7XStreO4ohOwRb8IjoqG_LgL3Gu2fK6Vfbc1zChSyMnv7zidvkNsOSH6ySZDtkfbU8M8_ITf19Na2Wu2RNDL8gHQtLJVB5SHedzcLRcVjTEVL6CSn7aOnwF0EGSgE
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VglQkxKNQMC10kXhcMLU39np9QKiCllZtogoFqTezWa9LpMQpcUrErf8Bfgc_qr-EmfWDGhVuPXD2eP2a-WZmPfMNwFONLiAwsuOqcBC5gVS-O9Boj1GktVSo1jpN7bCJqNeTh4fxwQL8rHthqKyyxkQL1OlE0x75Bo9CGs-N_v_N8ReXpkbR39V6hEapFnvm2xxTtuL17jv8vs84397qv91xq6kCrhaBP3MlQo0WqYrRsws-CIly0w9NFhstpAyzWKELy9Axh6kYoPc2QaDTKFaRh6GTF2cdXPcKXCVePeLq73r9c-G2nW1CWYeLSBBWJJEhrrUxHs-nr8bjCEMo5becYOUKynLIiwLdP-s1zznA7Vv_26u7DTerUJttlrZxBxZMvgxLdSd2sQw3yj1LVrZi3YX3B1SshtDP-raYmH0wR3anlHWNKkamYFsjOwSNlJmdnf5gthRpPkzNS0bNSGen3zkGxvfg46U81wos5pPcPADmy0z4mWdkaHgguKcQ8EQklPZ8FWM454Bbf_lEVyzsNAxklFA2RpqSkKYktaY48KKRPy75R_4quU6KlJT9sw1wJZtC8gCRV0hcy0oQdOE1tao6MPDOiQSsJfm8JXlUUqBfJLjWEkRs0q3DK1arm1vnGNBG6F4deFKrakLnUKVfbiYnRYLpuAiIBVE4sNrIVD_Qkt-q7MD90iiatTsB5r5oew5ELXNpBIhJvX0kH362jOoST-Re5-E_r7gOSzv97n6yv9vbW4XrnIqbqB6Ur8HibHpiHsE1_XU2LKaPLSow-HTZtvQLR8ObwA
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progress+Toward+Regional+Measles+Elimination+%E2%80%94+Worldwide%2C+2000%E2%80%932020&rft.jtitle=MMWR.+Morbidity+and+mortality+weekly+report&rft.au=Dixontt+Ferrari%2C+Meredith+G&rft.au=Antoni%2C+Sebastien&rft.au=Li%2C+Xi&rft.au=Portnoy%2C+Allison&rft.date=2021-11-12&rft.pub=U.S.+Center+for+Disease+Control&rft.issn=0149-2195&rft.eissn=1545-861X&rft.volume=70&rft.issue=45&rft.spage=1563&rft_id=info:doi/10.15585%2Fmmwr.mm7045a1
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-2195&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-2195&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-2195&client=summon